Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pala

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Cancer Treatment Reviews|August 10, 2015
The role of systemic therapy in the management of sinonasal cancer: A critical reviewPaolo Bossi, Nabil F Saba, Jan B Vermorken, et al.
JNCI Cancer Spectrum|August 20, 2025
Heterogeneity of progression-free-survival surrogacy by sex in randomized trials testing immunotherapy in NSCLCEleonora Pagan, Isabella Sala, Laura Pala, et al.
Eclinicalmedicine|July 15, 2024
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysisLaura Pala, Eleonora Pagan, Isabella Sala, et al.
Redox Biology|September 1, 2020
Targeting succinate dehydrogenase with malonate ester prodrugs decreases renal ischemia reperfusion injuryTimothy E Beach, Hiran A Prag, Laura Pala, et al.
The Lancet. Oncology|September 12, 2022
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trialFabio Conforti, Paolo Andrea Zucali, Laura Pala, et al.
Journal of the National Cancer Institute|March 4, 2025
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugatesLaura Pala, Federico Merlo, Isabella Sala, et al.
Journal of Geriatric Oncology|January 14, 2020
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre studyLaura Ridolfi, Francesco De Rosa, Elisabetta Petracci, et al.
Oncotarget|June 1, 2017
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic areaSalvatore Alfieri, Nicola Alessandro Iacovelli, Sara Marceglia, et al.
Cardiovascular Drugs and Therapy|July 11, 2020
Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In VivoHiran A Prag, Laura Pala, Duvaraka Kula-Alwar, et al.
Cancers|January 25, 2025
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME)Chiara Catania, Sara Manglaviti, Paolo Zucali, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reviews|August 10, 2015
The role of systemic therapy in the management of sinonasal cancer: A critical reviewPaolo Bossi, Nabil F Saba, Jan B Vermorken, et al.
JNCI Cancer Spectrum|August 20, 2025
Heterogeneity of progression-free-survival surrogacy by sex in randomized trials testing immunotherapy in NSCLCEleonora Pagan, Isabella Sala, Laura Pala, et al.
Eclinicalmedicine|July 15, 2024
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysisLaura Pala, Eleonora Pagan, Isabella Sala, et al.
Redox Biology|September 1, 2020
Targeting succinate dehydrogenase with malonate ester prodrugs decreases renal ischemia reperfusion injuryTimothy E Beach, Hiran A Prag, Laura Pala, et al.
The Lancet. Oncology|September 12, 2022
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trialFabio Conforti, Paolo Andrea Zucali, Laura Pala, et al.
Journal of the National Cancer Institute|March 4, 2025
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugatesLaura Pala, Federico Merlo, Isabella Sala, et al.
Journal of Geriatric Oncology|January 14, 2020
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre studyLaura Ridolfi, Francesco De Rosa, Elisabetta Petracci, et al.
Oncotarget|June 1, 2017
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic areaSalvatore Alfieri, Nicola Alessandro Iacovelli, Sara Marceglia, et al.
Cardiovascular Drugs and Therapy|July 11, 2020
Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In VivoHiran A Prag, Laura Pala, Duvaraka Kula-Alwar, et al.
Cancers|January 25, 2025
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME)Chiara Catania, Sara Manglaviti, Paolo Zucali, et al.
Pageof 13